Nicole Ferko

Papers

Total Citations

H-Index

About

Nicole Ferko is a leading health outcomes researcher whose work bridges clinical evidence and real-world patient care, with a particular focus on oncology and surgical outcomes. Her research centers on understanding long-term disease trajectories, especially in non-small cell lung cancer (NSCLC), where she has made significant contributions to quantifying recurrence risks after surgical resection. Her highly cited 2023 study, "Recurrence-Free Survival in Patients With Surgically Resected Non-Small Cell Lung Cancer," which has garnered 66 citations, provides a critical summary estimate of postsurgical recurrence-free survival—a key benchmark that was previously lacking in the literature. This work has helped clinicians and patients set more accurate expectations for recovery and long-term prognosis, and it informs treatment planning and adjuvant therapy decisions. Beyond this landmark paper, Ferko’s broader portfolio includes systematic reviews and meta-analyses that synthesize complex clinical data into actionable insights. Her research is widely referenced by surgeons, oncologists, and health policy makers, underscoring her role in shaping evidence-based standards for cancer care. For students and researchers, Ferko exemplifies how rigorous outcomes research can directly improve patient counseling and clinical decision-making.